{"name":"Orthofix Medical Inc.","slug":"orthofix","ticker":"OFIX","exchange":"NASDAQ","domain":"orthofix.com","description":"Orthofix Medical Inc., together with its subsidiaries, operates as a medical technology company in the United States, Italy, the United Kingdom, France, Germany, Brazil, and internationally. It operates through two segments, Global Spine and Global Limb Reconstruction. The Global Spine segment manufactures, distributes, and provides support services for bone growth stimulation devices that enhance bone fusion; designs, develops, and markets a portfolio of spine fixation implant products for use throughout the spinal column; and offers bone graft substitutes, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers in various forms with supporting graft delivery solutions to treat various spinal, orthopedic, and dental conditions. This segment also designs, develops, and markets a portfolio of navigation technologies, including tracked surgical tools, intelligent software, and imaging equipment ","hq":"Lewisville, TX","founded":0,"employees":"1605","ceo":"Massimo Calafiore","sector":"MedTech / Orthopedics & Spine","stockPrice":12.36,"stockChange":0.15,"stockChangePercent":1.23,"marketCap":"$500M","metrics":{"revenue":825374016,"revenueGrowth":1.6,"grossMargin":71,"rdSpend":65847000,"netIncome":-92192000,"cash":120278000,"dividendYield":0,"peRatio":14.5,"fiscalYear":"FY2025"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2023-08-03","type":"earnings","headline":"Orthofix Medical Inc. Reports Second Quarter 2023 Financial Results","summary":"Orthofix Medical Inc. reported its second-quarter 2023 financial results, with revenue of $134.1 million and a net loss of $2.4 million.","drugName":"","sentiment":"neutral"},{"date":"2022-11-14","type":"deal","headline":"Orthofix Medical Inc. Acquires SpineGuard","summary":"Orthofix Medical Inc. acquired SpineGuard, a French medical device company specializing in spinal surgery solutions.","drugName":"","sentiment":"positive"},{"date":"2022-05-09","type":"regulatory","headline":"Orthofix Medical Inc. Receives FDA Clearance for Pulsion System","summary":"Orthofix Medical Inc. received FDA clearance for its Pulsion System, a spinal implant designed for use in minimally invasive spine surgery.","drugName":"","sentiment":"positive"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiogJBVV95cUxNdTV6bm1rMThvN1pHekVjcVdDQmJJLXdVdFgyRmVMTzJxaEJ1eEhRUVN2UEM5cEoyTU9nb2htTDJ2UC1taE5ORFpYdFBXb2VDUm9vbUhwV25TeGxYdjRUME1qYW1nOTZQUmJCSUdreHVWNEVfRUR5Z3kxS1Z5RE5TLTdaNzdWVDBLcVh0aG1jd1JzYzgxaVpfdXBPRGlsRUpyaFppM2lBY3ZNR19NR0RVaUVfanZhNHZWazcwNGJydG9mcjB5S25WWmkzd0tINlR6NFNKTGRQclRrU3BsWmJsdldHVWZqZTJMNUVwLVNVVHVsbGlId0hfMHc5T1pHZXpIcU9meldnLVJtUVlXZ1JmVEtWUFpaYWQ3Zk1ndlhSanRQQQ?oc=5","date":"2026-04-01","type":"pipeline","source":"The Globe and Mail","summary":"Analysts Conflicted on These Healthcare Names: Phreesia (PHR), Viridian Therapeutics (VRDN) and Orthofix Medical (OFIX) - The Globe and Mail","headline":"Analysts Conflicted on These Healthcare Names: Phreesia (PHR), Viridian Therapeutics (VRDN) and Orthofix Medical (OFIX)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwJBVV95cUxNSEVXbzBWV2hSS3BkekN1Y1lHdXgzS2c0aC1LNzJIUDZ4MlVTLXVpZExKT2NUS0ZGbVlUVXVacHJhUWwwWXVhSW9hZFA1V1RXeUtrWVdUNzNuZS1YZ2RJRzl2UHM5RVhGTjdyNHk3X1NuNlk0ay1qeUYyNDNsam5tZDhxMkVTR0o5OWVHWEk3OF9rMUFoLXNmVDFoT3VXUGp1em9MTmh4aVFYQ2VLTkJDc0dwclVYRnZyUWhVOUNZYUNOcy15V2x3MTFIOVRJbFJudVNUcUtKZ1RXblIxTDlIcjYwMk9lTXo4VVdGOHhlem5TNGg5VXQ5dURGdmpmbU1tblh3VFVVU1ozZXhhOEM0ajNLVktJdDR2WjJRN19lZHJQT0NZMWJqeDlFTjJlQkk?oc=5","date":"2026-03-11","type":"pipeline","source":"Business Wire","summary":"OFIX Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Orthofix Medical Inc. – OFIX - Business Wire","headline":"OFIX Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers","sentiment":"neutral"},{"date":"2026-02-24","type":"earnings","source":"SEC EDGAR","summary":"10-K filed with SEC: 10-K","headline":"Annual Report (10-K) Filed","sentiment":"neutral"},{"date":"2026-02-24","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizAFBVV95cUxNLWI1YVA0SHduNnZ5RTBLUU0tZEhZTlRWUVZrYUloTEcweEFmQmx3OTNlbm5PVktYdThpSy0ycndRT1N0V2VBR3o2SUFRYURvMnZuN245ZkJhMGFLZFByakl1OTN0S1FYWmtZZ2JCNk1raVVKUjFhQzBuTTdYOXMzWHhvTVI5SVZ5Nk1jOVBiVHotS3lpVUlSZUN5VnlrdzFTOGR4U2xwR1pWWVN3alZtMWlPQ204VEFWTGtQT0hqTy02ZUxtVUJpSHhXeFU?oc=5","date":"2024-03-18","type":"pipeline","source":"Business Wire","summary":"Lucas Vitale Joins Orthofix as Chief People and Business Operations Officer - Business Wire","headline":"Lucas Vitale Joins Orthofix as Chief People and Business Operations Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxNM0o5ZXItdm51RW5lRkxfNHBDMm1WS1JvS29rOGpKdTFhQl85MkJXMUs3TDNuSkRRWW81U1RvMnRQaXZsZmExLXNvZFlkeURQNEo1dVh1UjRobVhiY3lkVklrSWxKNjVnaWNhdlRQN2NMY0N4WjZMajRhQkRtbWVSZWgzMGZNdW9MSktKLWZCT1pWYms1cjE3d0pfbkZ0TDVnU1luX1lHMk1zeG1rZVhobHQ0VFVLNVlpeUM0YTEzd2pEZw?oc=5","date":"2024-02-29","type":"pipeline","source":"Business Wire","summary":"Orthofix Announces New President for Bone Growth Therapies Business - Business Wire","headline":"Orthofix Announces New President for Bone Growth Therapies Business","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiygFBVV95cUxQR0VaN1dnX1htdzBfZHhGT1ZIRDZSLXlpaTdNWDRfWVRHQ1M2LTJwWE5zNVJUWnNCdDFRelRjNnJzeW5iWmpITGQwaWRRc3BKV2V1UlJBelM4RHRicFRJMzVxUXNQRGtDdlcyR3FRUkJhY19HakFZd0RwZUVxNUgwZTc4cjR2OG9XTUhRUmRkRDY5NGFpLU5NSmNBQW05S05pN3o0M3JiQzBvNXdiX0hEdGp0XzE2S214a3FUZGtmMUJGS2lNblJEYjdn?oc=5","date":"2023-11-28","type":"pipeline","source":"Business Wire","summary":"Orthofix Names Massimo Calafiore as President and Chief Executive Officer - Business Wire","headline":"Orthofix Names Massimo Calafiore as President and Chief Executive Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxPZ1dFMUJsZ2ZaMUFaMVI0X0NpZm50MldOX1NTQ29ZVHhEWFlRTHlLaElyODE2YWpNOXVfTUFvLWRfVWJzQU16aEZLVjlXZktCQ0cwbFY0TjdmWXVHQlZmZ2NXTFBuUjJaSWhROGxSYk0wSExJV2lvMEl2clNVYUJFS1U3aXYtWVdPbmVDSDVxRXhWRXhlN0FTTXZ3?oc=5","date":"2023-09-12","type":"pipeline","source":"Business Wire","summary":"Orthofix Announces Leadership Changes - Business Wire","headline":"Orthofix Announces Leadership Changes","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-AFBVV95cUxNNnBpdHF5WEhrME1oNC13Q183UXZaTV9JTTIzYllDRWFRSi1sYTBtc05kdFo3bWlVMnlRZ2pLakY0REZldzZZYUZCRzBWSHVaUTc4U296VVB6MkFTakZHcE9sTHlCa1lIdTFMVTFCRldVeGdqNnI1RldJVUhQUzRqMHZEekFXSHN5Y1Fpa2lKNzVxNnhKbTV0bzRlanlkYk1DTm0waXRtek5ySlV1eGFza3NDX3Y3M29ZLWlmTFB6dzIzSGZZbGN6cDRGd1d1eDJLWTU5Sks0VFk0MXRQNmtXYms4WllFVVBWVkVzOWJQWFNHN25IdXpuUA?oc=5","date":"2022-08-02","type":"deal","source":"Business Wire","summary":"Orthofix Medical and CGBio Announce Strategic Partnership Agreement for Novosis rhBMP-2 Bone Graft Solutions - Business Wire","headline":"Orthofix Medical and CGBio Announce Strategic Partnership Agreement for Novosis rhBMP-2 Bone Graft Solutions","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2gFBVV95cUxOci0xMDlXc3p0ZGQ2WHV6d180a0JGalpaMG9rTGY0cVVkX1dZOW1sUnYxQ1FUZlpDamNvSThTQnFJazRRSG0wQXdqTGpMU3RYbi1SUURFYlBWdTQzdS10N1JzUkdaSHpNQlQwQ1RYdmZJYlk3QnFPQ0k5TDVxYUQwM05lWGRkZEsyTUppNmVXd2c2cGRybEVkSUxrR05JTVpsTThfTVpUTVduZDVnaDBNRVNnVGFuNXo5VkdZV3FDVl9yOHlWaVRKZ0hrVmIwaGVLekVFQUVXLTFBQQ?oc=5","date":"2021-07-12","type":"trial","source":"BioSpace","summary":"Publication of Data Shows High Fusion Rate in Patients Treated with PEMF Therapy Using the Orthofix SpinalStim Device - BioSpace","headline":"Publication of Data Shows High Fusion Rate in Patients Treated with PEMF Therapy Using the Orthofix SpinalStim Device","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxPaHRiT2FETzExcklZTWFEVklsV2FXeWtfOVlLakxGQmZyUndwMVhjWjJUem1BcE1hQ01SU1hya2EyUUctUFBwc1ZQQzBqNmR1SG9xMER6OHhBVGg0QmhldC0wTVBncDNPeE44bHhyOEtTTGNHaElJcURENjc1X0ZUVGg1MTBYdFFaYnRiempMaHJnZm1jNmNDRi1jazk?oc=5","date":"2020-02-04","type":"deal","source":"BioSpace","summary":"Orthofix Announces Agreement to Acquire FITBONE Limb Lengthening System - BioSpace","headline":"Orthofix Announces Agreement to Acquire FITBONE Limb Lengthening System","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["Stryker Corporation (SYK)","Medtronic plc (MDT)","Zimmer Biomet Holdings Inc. (ZBH)"],"therapeuticFocus":["Spinal Disorders","Orthopedic Trauma","Degenerative Diseases"],"financials":{"source":"sec_edgar+yahoo","revenue":822312000,"revenuePeriod":"2025-12-31","revenueHistory":[{"value":822312000,"period":"2025-12-31"},{"value":799491000,"period":"2024-12-31"},{"value":799491000,"period":"2024-12-31"},{"value":746641000,"period":"2023-12-31"},{"value":746641000,"period":"2023-12-31"}],"grossProfit":566017000,"grossProfitHistory":[{"period":"2025-12-31","value":566017000},{"period":"2024-12-31","value":545885000},{"period":"2023-12-31","value":486273000},{"period":"2022-12-31","value":337169000}],"rdSpend":65847000,"rdSpendHistory":[{"period":"2025-12-31","value":65847000},{"period":"2024-12-31","value":73643000},{"period":"2023-12-31","value":80231000},{"period":"2022-12-31","value":49065000}],"sgaSpend":554329000,"operatingIncome":-82568000,"operatingIncomeHistory":[{"period":"2025-12-31","value":-82568000},{"period":"2024-12-31","value":-77719000},{"period":"2023-12-31","value":-141761000},{"period":"2022-12-31","value":-28868000}],"netIncome":-92192000,"netIncomeHistory":[{"period":"2025-12-31","value":-92192000},{"period":"2024-12-31","value":-125997000},{"period":"2023-12-31","value":-151395000},{"period":"2022-12-31","value":-19749000}],"eps":-2.33,"epsHistory":[{"period":"2025-12-31","value":-2.33},{"period":"2024-12-31","value":-3.3},{"period":"2023-12-31","value":-4.12},{"period":"2022-12-31","value":-0.98}],"cash":82025000,"cashHistory":[{"period":"2025-12-31","value":82025000},{"period":"2024-12-31","value":83238000},{"period":"2023-12-31","value":33107000},{"period":"2022-12-31","value":50700000}],"totalAssets":850647000,"totalLiabilities":400610000,"totalDebt":178435000,"equity":450037000,"operatingCashflow":33347000,"operatingCashflowHistory":[{"period":"2025-12-31","value":33347000},{"period":"2024-12-31","value":25790000},{"period":"2023-12-31","value":-45753000},{"period":"2022-12-31","value":-11538000}],"capex":-34626000,"capexHistory":[{"period":"2025-12-31","value":-34626000},{"period":"2024-12-31","value":-34876000},{"period":"2023-12-31","value":-62050000},{"period":"2022-12-31","value":-23160000}],"freeCashflow":-1279000,"dividendsPaid":null,"buybacks":null,"employees":1605,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[{"sga":134911000,"ebit":-15170000,"ebitda":-619000,"period":"2026-03-31","revenue":196708000,"epsBasic":-0.52,"netIncome":-20908000,"rdExpense":15320000,"epsDiluted":-0.52,"grossProfit":139546000,"operatingIncome":-13686000},{"sga":136753000,"ebit":2159000,"ebitda":17212000,"period":"2025-12-31","revenue":219911000,"epsBasic":-0.06,"netIncome":-2222000,"rdExpense":15373000,"epsDiluted":-0.06,"grossProfit":156342000,"operatingIncome":1154000},{"sga":148102000,"ebit":-17581000,"ebitda":-3058000,"period":"2025-09-30","revenue":205634000,"epsBasic":-0.57,"netIncome":-22795000,"rdExpense":14774000,"epsDiluted":-0.57,"grossProfit":148523000,"operatingIncome":-17473000},{"sga":136493000,"ebit":-10273000,"ebitda":7724000,"period":"2025-06-30","revenue":203121000,"epsBasic":-0.36,"netIncome":-14081000,"rdExpense":15934000,"epsDiluted":-0.36,"grossProfit":139533000,"operatingIncome":-16766000},{"sga":132981000,"ebit":-47627000,"ebitda":-11945000,"period":"2025-03-31","revenue":193646000,"epsBasic":-1.35,"netIncome":-53094000,"rdExpense":19766000,"epsDiluted":-1.35,"grossProfit":121619000,"operatingIncome":-49483000},{"sga":null,"ebit":null,"ebitda":null,"period":"2024-09-30","revenue":null,"epsBasic":null,"netIncome":null,"rdExpense":null,"epsDiluted":null,"grossProfit":null,"operatingIncome":null}]},"ciks":null,"lastFiledAt":null},"yahoo":{"currentPrice":12.36,"previousClose":12.21,"fiftyTwoWeekHigh":16.99,"fiftyTwoWeekLow":10.24,"fiftyTwoWeekRange":"10.24 - 16.99","fiftyDayAverage":12.08,"twoHundredDayAverage":13.88,"beta":0.79,"enterpriseValue":635525376,"forwardPE":14.5,"priceToBook":1.09,"priceToSales":0.61,"enterpriseToRevenue":0.77,"enterpriseToEbitda":37.38,"pegRatio":8.32,"ebitda":17004000,"ebitdaMargin":2.1,"freeCashflow":22024250,"operatingCashflow":34128000,"totalDebt":262255008,"debtToEquity":60.3,"currentRatio":2.87,"returnOnAssets":-3.3,"returnOnEquity":-13.4,"analystRating":"2.0 - Buy","recommendationKey":"buy","numberOfAnalysts":4,"targetMeanPrice":17.25,"targetHighPrice":20,"targetLowPrice":14,"dividendRate":0,"payoutRatio":0,"fiveYearAvgDividendYield":0,"exDividendDate":0,"insiderHeldPercent":1.9,"institutionHeldPercent":90.4,"sharesOutstanding":40421652,"floatShares":39830283,"sharesShort":1237366,"shortRatio":5.35,"shortPercentOfFloat":3.1,"epsTrailing":-1.5,"epsForward":0.85,"revenuePerShare":20.68,"bookValue":11.3,"officers":[{"age":53,"name":"Mr. Massimo  Calafiore","title":"President, CEO & Director"},{"age":54,"name":"Ms. Julie B. Andrews","title":"Chief Financial Officer"},{"age":48,"name":"Ms. Aviva  McPherron","title":"President of Global Operations & Quality"},{"age":44,"name":"Mr. J. Andres Cedron","title":"Chief Legal Officer & Corporate Secretary"},{"age":51,"name":"Mr. Patrick  Fisher","title":"President of Global Biologics & Limb Reconstruction"},{"age":null,"name":"Mr. Geoffrey C. Gillespie","title":"Chief Accounting Officer"},{"age":64,"name":"Ms. Julie D. Dewey","title":"Chief Investor Relations & Communications Officer"},{"age":null,"name":"Ms. Jill  Mason","title":"Chief Compliance & Risk Officer"}],"industry":"Medical Devices","irWebsite":"","website":"https://orthofix.com","phone":"214 937 2000"}}